World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
11856
World Ranking
3877
National Ranking
1777

Research.com Recognitions

  • 1958 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Cara Haymaker is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on fields related to Medicine and Biochemistry, Genetics and Molecular Biology, with significant work in Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

Their research topics encompass a range of areas within cancer and immunology, including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Immune Cell Function and Interaction
  • Cancer Research and Treatments

Cara Haymaker has contributed to numerous scientific publications. Some recent notable papers include:

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, published in Nature Medicine
  • Identification of bacteria-derived HLA-bound peptides in melanoma, 2021, published in Nature
  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity, 2022, published in Cancer Cell
  • Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02), 2020, published in Cancer Discovery
  • Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial, 2023, published in Nature Medicine

Their frequent co-authors include Ignacio I. Wistuba, Chantale Bernatchez, Edwin R. Parra, Boris Sepesi, and John V. Heymach.

Cara Haymaker's work appears often in publication venues such as:

  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Journal for ImmunoTherapy of Cancer

Among the awards recorded, Cara Haymaker is recognized as a Fellow of the American Association for the Advancement of Science (AAAS), awarded in 1958.

Best Publications

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.

    Erminia Massarelli;William William;Faye Johnson;Merrill Kies

  • Identification of bacteria-derived HLA-bound peptides in melanoma

    Shelly Kalaora;Adi Nagler;Deborah Nejman;Michal Alon

  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

    Unknown

  • Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

    Richard Wu;Marie Andrée Forget;Jessica Chacon;Jessica Chacon;Chantale Bernatchez

  • Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.

    Edwin R. Parra;Naohiro Uraoka;Mei Jiang;Pamela Cook

  • Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

    Adi Diab;Nizar M. Tannir;Salah Eddine Bentebibel;Patrick Hwu

  • A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors

    Salah Eddine Bentebibel;Michael E. Hurwitz;Chantale Bernatchez;Cara Haymaker

  • TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.

    Alexandre Reuben;Rachel Gittelman;Jianjun Gao;Jiexin Zhang

  • Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma

    Peter Bailey;David K. Chang;Marie Andreé Forget;Francis A.San Lucas

  • Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.

    Edwin R. Parra;Pamela Villalobos;Carmen Behrens;Mei Jiang

  • Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.

    Meenu Sharma;Hiep Khong;Faisal Fa’ak;Salah Eddine Bentebibel

  • Hallmarks of Resistance to Immune-Checkpoint Inhibitors

    Unknown

  • Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

    Y. Kudo;Y. Kudo;C. Haymaker;J. Zhang;A. Reuben

  • Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

    Alexandre Reuben;Christine N. Spencer;Peter A. Prieto;Vancheswaran Gopalakrishnan

  • RNA editing derived epitopes function as cancer antigens to elicit immune responses

    Minying Zhang;Jens Fritsche;Jason Roszik;Leila J. Williams

  • Batf is important for IL-4 expression in T follicular helper cells.

    Anupama Sahoo;Andrei Alekseev;Kentaro Tanaka;Kentaro Tanaka;Lidiya Obertas

  • Delayed maturation of an IL-12–producing dendritic cell subset explains the early Th2 bias in neonatal immunity

    Unknown

  • Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.

    Hitoshi Dejima;Xin Hu;Runzhe Chen;Jiexin Zhang

  • Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.

    L. Federico;D.J. McGrail;S.-E. Bentebibel;C. Haymaker

  • Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set

    Jason Roszik;Lauren E. Haydu;Kenneth R Hess;Junna Oba

  • FoxP3+RORγt+ T Helper Intermediates Display Suppressive Function against Autoimmune Diabetes

    Danielle M. Tartar;Amie M. VanMorlan;Xiaoxiao Wan;F. Betul Guloglu

  • PD-1 and BTLA and CD8+ T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint

    Cara Haymaker;Richard C. Wu;Chantale Bernatchez;Laszlo G. Radvanyi

  • T-cell agonists in cancer immunotherapy.

    Yeonjoo Choi;Yaoyao Shi;Cara L Haymaker;Aung Naing

Frequent Co-Authors

Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Don L. Gibbons
Don L. Gibbons The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Laszlo Radvanyi
Laszlo Radvanyi Ontario Institute for Cancer Research
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
Jason Roszik
Jason Roszik The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to diverse healthcare and research careers. For those interested in nursing pathways, advanced clinical roles offer promising opportunities. Nurse Practitioners (NPs) specializing in acute care need specific training, and exploring acnp programs can guide you through the transition process effectively.

Accelerated programs are also available for professionals looking to fast-track their nursing qualifications. If time is a factor, consider accelerated np programs online, which provide flexible learning tailored to busy schedules.

For individuals without a nursing background, enrolling in online rn programs for non nurses in florida can be a strategic starting point. These programs help non-nurses enter the nursing profession, enabling them to build the required foundation before advancing to specialized roles related to Immunology and patient care.

Understanding compensation is also crucial when planning your healthcare career path. Salary variations exist depending on the state, experience, and specialty. For insights into earning potential, reviewing data on how much do dnps make can help you make informed career decisions tailored to your goals and location.

Best Scientists Citing Cara Haymaker

Trending Scientists

Recently Published Articles